Research location
Bologna
BO, Italy
Advertisement
Research activity in Bologna
BO, ItalyCureCurrent currently publishes aggregate city-level research activity for this location: 80 trials and 89 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Bologna
79 linked trials · page 1 of 2VR and Orthoses for Rehabilitation in Multiple SclerosisNCT07096700 · 2026-03-02 · 1 site observation
RECRUITING
Randomized, Double-blind Crossover Trial Comparing Low-GI Functional vs. Standard Wholegrain Carbohydrates on Glycolipid Metabolism and Vascular Stress Markers in Adults With Suboptimal TriglyceridemiaNCT07198789 · 2026-02-02 · 1 site observation
RECRUITING
Multifactorial Strategies for the Prevention of the Risks of Ulceration in Patients Affected by Diabetic Foot (DARE-DiaFoot)NCT07021222 · 2025-11-03 · 1 site observation
RECRUITING
A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney DiseaseNCT06717698 · 2024-12-02 · 1 site observation
RECRUITING
Cardiometabolic Risk of Obese Subjects: Cross-sectional StudyNCT06714058 · 2024-11-30 · 1 site observation
RECRUITING
Whole Body MRI in OncologyNCT06895291 · 2023-10-26 · 1 site observation
RECRUITING
Patients With Diabetes Mellitus on Drug Treatment on the List or Already Undergoing Orthotopic Liver TransplantationNCT06816303 · 2021-11-19 · 1 site observation
RECRUITING
Motor and Cognitive Telerehabilitation in a Virtual Environment in Patients With Post-stroke Sequelae and Parkinson's DiseaseNCT07582497 · 2026-06-01 · 1 site observation
NOT_YET_RECRUITING
A Multicenter Open-label Phase II Study of Cemiplimab Plus Chemotherapy, Selected on the Basis of Baseline Cytidine Deaminase Activity, in Advanced Squamous Non-small Cell Lung CancerNCT07418931 · 2026-05-01 · 1 site observation
NOT_YET_RECRUITING
"Observational, Retrospective and Prospective, Non-interventional, Multicentre on the Use of Genomic Testing in the Management of Early Stage HR+/HER2- Breast Cancer"NCT06871501 · 2025-03-01 · 1 site observation
NOT_YET_RECRUITING
Transcripts with Retained H/ACA Box SnoRNA Sequences As Biomarkers for Estrogen Dependence in Lum-B Breast CarcinomasNCT06805084 · 2024-12-01 · 1 site observation
ACTIVE_NOT_RECRUITING
Evaluation of the Performance and Safety of Hyalo Gyn® Gel Compared to Placebo in Postmenopausal Breast Cancer SurvivorsNCT06922136 · 2024-08-01 · 1 site observation
ACTIVE_NOT_RECRUITING
BRING-UP 3 Heart FailureNCT06279988 · 2023-09-15 · 2 site observations
UNKNOWN
An Efficacy, Safety, Tolerability and Dose Finding Study of XXB750 in Resistant Hypertension Patients.NCT05562934 · 2022-11-08 · 1 site observation
COMPLETED
Impact of Mayzent on aSPMS Patients in a Long-term NIS in ItalyNCT05376579 · 2022-06-17 · 1 site observation
COMPLETED
Study to Assess the Efficacy and Safety of Alpelisib Plus Fulvestrant in Participants With HR-positive (HR+), HER2-negative, Advanced Breast Cancer After Treatment With a CDK4/6 Inhibitor and an Aromatase Inhibitor.NCT05038735 · 2021-12-17 · 1 site observation
ACTIVE_NOT_RECRUITING
Adherence and Tolerability of Four Very Low-Calorie Ketogenic Diet Approaches in Adults With Obesity or Complicated OverweightNCT07389122 · 2021-07-01 · 1 site observation
COMPLETED
Identification of the Risk of Remote Pulmonary Hypertension in Preterm Births.NCT06800300 · 2021-06-01 · 1 site observation
COMPLETED
Study of Talazoparib With Enzalutamide in Men With DDR Gene Mutated mCSPCNCT04821622 · 2021-05-12 · 1 site observation
ACTIVE_NOT_RECRUITING
Observational Study of Eating Behavior in Patients With Diabetes Mellitus and Obesity Undergoing Liver TransplantationNCT06714786 · 2021-04-30 · 1 site observation
ACTIVE_NOT_RECRUITING
Global Prevalence of ATTR-CM in Participants With HFpEFNCT04424914 · 2020-12-30 · 1 site observation
TERMINATED
Identification of Palliative Care Needs and Prognostic Factors of Survival in Tailoring Appropriate Interventions in Advanced Oncological, Renal and Pulmonary DiseasesNCT06909968 · 2020-12-14 · 3 site observations
COMPLETED
Study of Capmatinib and Spartalizumab/Placebo in Advanced NSCLC Patients With MET Exon 14 Skipping MutationsNCT04323436 · 2020-08-19 · 1 site observation
TERMINATED
Retrospective Case Series of COVID19+ Patients Undergoing Orthopedic SurgeryNCT05881343 · 2020-07-18 · 1 site observation
COMPLETED
Open-label Extension Study to Evaluate Long-term Safety of Sacubitril/Valsartan in Pediatric Patients With HFNCT03785405 · 2019-05-02 · 1 site observation
COMPLETED
A Trial to Evaluate Efficacy and Safety of Ribociclib With Endocrine Therapy as Adjuvant Treatment in Patients With HR+/HER2- Early Breast CancerNCT03701334 · 2018-12-07 · 1 site observation
ACTIVE_NOT_RECRUITING
Study of the Molecular Features of Postmenopausal Women With HR+ HER2-negative aBC on First-line Treatment With Ribociclib and Letrozole and, in Patients With a PIK3CA Mutation, on Second-line Treatment With Alpelisib Plus FulvestrantNCT03439046 · 2018-02-02 · 1 site observation
TERMINATED
Talazoparib + Enzalutamide vs. Enzalutamide Monotherapy in mCRPCNCT03395197 · 2017-12-18 · 1 site observation
ACTIVE_NOT_RECRUITING
Study Assessing the Efficacy and Safety of Alpelisib Plus Fulvestrant or Letrozole, Based on Prior Endocrine Therapy, in Patients With PIK3CA Mutant, HR+, HER2- Advanced Breast Cancer Who Have Progressed on or After Prior TreatmentsNCT03056755 · 2017-08-29 · 1 site observation
COMPLETED
Roll-over Study to Collect and Assess Long-term Safety of Everolimus in Patients With TSC and Refractory Seizures Who Have Completed the EXIST-3 Study [CRAD001M2304] and Who Are Benefitting From Continued TreatmentNCT02962414 · 2017-08-23 · 1 site observation
ACTIVE_NOT_RECRUITING
A Randomized, Double-blind Controlled Study Comparing LCZ696 to Medical Therapy for Comorbidities in HFpEF PatientsNCT03066804 · 2017-08-22 · 1 site observation
COMPLETED
CDK4/6-inhibitor or Chemotherapy, in Combination with ENDOcrine Therapy, for Advanced Breast Cancer / KENDONCT03227328 · 2017-08-02 · 1 site observation
COMPLETED
BLITZ Heart FailureNCT03661060 · 2017-03-08 · 3 site observations
COMPLETED
Prospective ARNI vs ACE Inhibitor Trial to DetermIne Superiority in Reducing Heart Failure Events After MINCT02924727 · 2016-12-09 · 1 site observation
COMPLETED
Study to Assess the Safety and Efficacy of Ribociclib (LEE011) in Combination With Letrozole for the Treatment of Men and Pre/Postmenopausal Women With HR+ HER2- aBCNCT02941926 · 2016-11-30 · 2 site observations
COMPLETED
Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of LCZ696 Followed by a 52-week, Double-blind Study of LCZ696 Compared With Enalapril in Pediatric Patients With Heart FailureNCT02678312 · 2016-11-03 · 1 site observation
COMPLETED
Adjuvant Treatment for High-risk Triple Negative Breast Cancer Patients With the Anti-PD-l1 Antibody AvelumabNCT02926196 · 2016-06-17 · 2 site observations
COMPLETED
Study of Oral cMET Inhibitor INC280 in Patients With EGFR Wild-type (wt), Advanced Non-small Cell Lung Cancer (NSCLC) (Geometry Mono-1)NCT02414139 · 2015-06-11 · 1 site observation
COMPLETED
Study of Safety and Efficacy of LEE011 and Ceritinib in Patients With ALK-positive Non-small Cell Lung Cancer.NCT02292550 · 2015-05-14 · 1 site observation
COMPLETED
"Neo-Adjuvant Treatment With Palbociclib: Effect on Ki67 and Apoptosis Before, During and After Treatment "NCT02530424 · 2015-05-01 · 1 site observation
COMPLETED
Phase I/II Study of PDR001 in Patients With Advanced MalignanciesNCT02404441 · 2015-04-27 · 1 site observation
COMPLETED
Pharmacokinetic and Safety Study of Lower Doses of Ceritinib Taken With a Low-fat Meal Versus 750 mg of Ceritinib in the Fasted State in Adult Patients With (ALK-positive) Metastatic Non-small Cell Lung Cancer (NSCLC)NCT02299505 · 2015-04-09 · 1 site observation
COMPLETED
CINC424A2X01B Rollover ProtocolNCT02386800 · 2015-03-05 · 1 site observation
ACTIVE_NOT_RECRUITING
Study of Safety and Efficacy of EGFR-TKI EGF816 in Combination With cMET Inhibitor INC280 in Adult Patients With EGFR Mutated Non Small Cell Lung Cancer.NCT02335944 · 2015-01-13 · 1 site observation
TERMINATED
Trajectory Changes of Coronary Sinus Lead Tip and Cardiac Resynchronization Therapy OutcomeNCT02340546 · 2015-01-01 · 1 site observation
COMPLETED
Study of Efficacy and Safety in Premenopausal Women With Hormone Receptor Positive, HER2-negative Advanced Breast CancerNCT02278120 · 2014-11-20 · 1 site observation
COMPLETED
ß-SPECIFIC 4 Patients: Study of Pediatric EffiCacy and Safety wIth FIrst-line Use of CanakinumabNCT02296424 · 2014-11-17 · 1 site observation
COMPLETED
Safety And Efficacy Study Of Bosutinib In Patients With Philadelphia Chromosome Positive Chronic Myeloid Leukemia Previously Treated With One Or More Tyrosine Kinase InhibitorsNCT02228382 · 2014-11-07 · 1 site observation
TERMINATED
Regional Registry-based Biobank Development and Pharmacogenetic Analysis in Rheumatoid ArthritisNCT03555240 · 2014-10-27 · 2 site observations
COMPLETED
Different Dosages of Bioactive Wheat Peptides and Blood Pressure Level and CVD Risk Biomarkers in Healthy SubjectsNCT02197910 · 2014-10-01 · 1 site observation
UNKNOWN
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.